Transparency is the Victim
By The Hindu,
The Hindu
| 01. 27. 2013
Expansion and proliferation of assisted reproductive technologies (ART) has been facilitated by economic globalisation wherein reproductive tissues like sperm, ova, and uteri are traded like any other commodity to make profit, says a new study, adding that India has emerged as the surrogacy outsourcing capital of the world.
Titled ‘Reproductive Tourism in India: Actors, Agencies and Contemporary Transnational Networks’, the study was conducted by the Centre of Social Medicine and Community Health, JNU, Sama-Resource Group for Women and Health and King’s College London.
The study focuses on the scenario in New Delhi where a large number of private hospitals and government institutions offer ART. It was found that public sector institutions offer only altruistic surrogacy services which are medically indicated. Leading obstetricians and gynaecologists from a top government-run hospital admitted that they have performed in-vitro fertilisation (IVF) in some cases where they were not sure if it was altruistic surrogacy.
One doctor said that she once had a patient, a doctor by profession who bore a surrogate baby for her sister-in-law who was also a doctor, married to a doctor...
Related Articles
By Julia Métraux, Mother Jones | 02.10.2026
Why was Jeffrey Epstein obsessed with genes? In the latest tranche of Epstein records and emails made available by the Department of Justice, themes of genes, genetics, and IQ—alongside more explicit threads of white supremacy—keep cropping up, often adjacent to Epstein’s...
By Teddy Rosenbluth, The New York Times | 02.09.2026
Dr. Mehmet Oz has urged Americans to get vaccinated against measles, one of the strongest endorsements of the vaccine yet from a top health official in the Trump administration, which has repeatedly undermined confidence in vaccine safety.
Dr. Oz, the...
By Ava Kofman, The New Yorker | 02.09.2026
1. The Surrogates
In the delicate jargon of the fertility industry, a woman who carries a child for someone else is said to be going on a “journey.” Kayla Elliott began hers in February, 2024, not long after she posted...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...